Design and synthesis of pyrido[1,2-e]purin-4(3H)-one derivatives as potential PDE 5 inhibitors

Chinese Chemical Letters

Volumn 16, Issue 10, 2005, Pages 1283-1286

  Xia, Guang Xin ^a,c   Li, Jian Feng ^a,c   Lai, Shun An ^b   Peng, Ai Ming ^b   Zhang, Shu Jun ^a   Wei, Xiao Hui ^a   Chen, Xin Jian ^a   Shen, Jing Shan ^a   Ji, Ru Yun ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b Topharman Shanghai Co Ltd   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Erectile dysfunction (ED); PDE5 inhibitor; Pyrido 1,2 e purin 4(3H) one; Sildenafil

Indexed keywords

EID: 33745026185     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. D. P. Rotella, Nat. Rev. Drug Discov., 2002, 1, 674.
2. S. H. Francis, I. V. Turko, J. D. Corbin, Prog. Nucleic Acid Res. Mol. Biol., 2000, 65, 1.
3. J. C. Lanter, Z. Sui, M. J. Macielag, et al., J Med. Chem., 2004, 47, 656.
4. J. A. Beavo, Physiol Rev., 1995, 75, 725.
5. D. A. Fox, M. L. Campbell, Y. S. Blocker, Neurotoxicology, 1997, 18, 645.
6. D. P. Rotella, Z. Sun, Y. Zhu, et al., J. Med. Chem., 2000, 43, 1257.
7. N. K. Terrett, A. S. Bell, D. Brown, et al., Bioorg. Med. Chem. Lett., 1996, 6, 1819.
8. H. Haning, U. Niewöhner, T. Schenke, et al., Bioorg. Med. Chem. Lett., 2002, 12, 865.
9. J. C. Teulade, R. Escale, J. C. Rossi, et al., Aust. J. Chem., 1982, 35, 1761.
10. F. Pinguet, S. Mavel, C. Galtier, et al., Pharmazie, 1999, 54, 876.
11. D. K. Kim, N. Lee, J. Y. Lee, et al., Bioorg. Med. Chem., 2001, 9, 1609.
12. Seiler, E. Gillespie, A. J. Arnold, et al., Thromb Res., 1991, 62, 31.
13. 1H-NMR data of 3A1, 3B1 were deposited in editorial office of CCL.